Table 1 Clinical characteristics of the study group (n = 195).

From: Simultaneous analysis of tumor-infiltrating immune cells density, tumor budding status, and presence of lymphoid follicles in CRC tissue

Gender

Male, n = 116 (59.49%)

Female, n = 79 (40.51%)

Age

< 60, n = 43 (22.05%)

60–69, n = 51 (26.15%)

70–79, n = 83 (42.57%)

≥ 80, n = 18 (9.23%)

Primary tumor location

Rectum, n = 83 (42.57%)

Sigmoid colon, n = 51 (26.15%)

Other parts of colon, n = 46 (23.59%)

Cecum, n = 15 (7.69%)

Histologic type

Adenocarcinoma n = 123 (63.07%)

Mucinous adenocarcinoma n = 72 (36.93%)

Histologic grade

G1, well‐differentiated, low grade, n = 1 (0.51%)

G2, moderately differentiated, n = 172 (88.21%)

G3, poorly differentiated, high grade, n = 22 (11.28%)

G4, undifferentiated, high grade, n = 0

T stage

T1, submucosa, n = 5 (2.56%)

T2, muscularis propria, n = 27 (13.85%)

T3, subserosa, n = 152 (77.95%)

T4, serosa or other organs, n = 11 (5.64%)

N stage

N0, absent, n = 113 (57.95%)

N1, present, n = 82 (42.05%)

M stage

M0 absent, n = 144 (73.85%)

M1 present, n = 51 (26.15%)

TNM stage

TNM-I, n = 26 (13.33%)

TNM-II, n = 64 (32.83%)

TNM-III, n = 54 (27.69%)

TNM-IV, n = 51 (26.15%)

Lymphovascular invasion

LVI-0, absent, n = 86 (44.1%)

LVI-1, present, n = 109 (55.9%)

Perineural invasion

PNI-0, absent, n = 149 (76.41%)

PNI-1, present, n = 46 (23.59%)